Table 1 |
||||
|
List of outcome measures |
||||
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
|
|
|
||||
|
Outcome group |
Glycaemic control evaluation outcomes |
Macrovascular complications preventive measures outcomes |
Microvascular complications preventive measures outcomes |
Economic evaluation outcomes |
|
Main outcome |
Proportion of patients who were prescribed 3 measurements of glycosilated haemoglobin with at least two months' interval |
Proportion of patients who were prescribed all macrovascular complications assessment tests (1) |
Proportion of patients who were prescribed all microvascular complications assessment tests (2) |
Marginal cost per each glycosilated haemoglobin measurement |
|
|
||||
|
(1)ECG+lipid assessment (totalcholesterol + HDL cholesterol + triglycerides). (2) Ophtalmologic visit + funduscopy + urine albumin + serum creatinine |
||||
|
Perria for the IMPLEMEG Study Group BMC Health Services Research 2004 4:13 doi:10.1186/1472-6963-4-13 |
||||
